rxstatShortages › Insulin Aspart

Insulin Aspart (Fiasp, Trurapi) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Sep 4, 2026

Also sold as: Fiasp, Trurapi, Novorapid, Kirsty

Some Insulin Aspart products are in shortage in Canada (1 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A rapid-acting insulin used to control blood sugar at mealtimes in diabetes.

Products affected
1 / 8
In shortage since
Sep 3, 2026
Reports on file
18
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TRURAPI
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02506572 · since Sep 3, 2026, no end estimate
Anticipated
TRURAPI
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02506564
Resolved
TRURAPI
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02506564 · ended Aug 12, 2026
Resolved
TRURAPI
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02506564 · ended Jun 30, 2026
Resolved
TRURAPI
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02506572 · ended Jun 30, 2026
Resolved
KIRSTY
100UNIT · SOLUTION · BIOCON SDN.BHD
DIN 02520974 · ended Jun 9, 2026 · Demand increase for the drug.
Resolved
FIASP
100UNIT · SOLUTION · NOVO NORDISK CANADA INC
DIN 02460416 · ended Mar 24, 2026 · Demand increase for the drug.
Resolved
TRURAPI
100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02506572 · ended Jan 16, 2026
Discontinued
FIASP
100UNIT · SOLUTION · NOVO NORDISK CANADA INC
DIN 02460424
Resolved
FIASP
100UNIT · SOLUTION · NOVO NORDISK CANADA INC
DIN 02460408 · ended Jul 30, 2025 · Manufacturing issues preventing production/release. Alternate products available: NovoRapid® Vials, Fiasp® FlexTouch®
Resolved
FIASP
100UNIT · SOLUTION · NOVO NORDISK CANADA INC
DIN 02460408 · ended Oct 28, 2024 · Delay in shipping of the drug.
Resolved
FIASP
100UNIT · SOLUTION · NOVO NORDISK CANADA INC
DIN 02460408 · ended Oct 2, 2024 · Delay in shipping of the drug.

Showing 12 of 18 reports. All reports are on file with Health Canada.

What's happening

Insulin Aspart is currently affected by an active shortage report filed with Health Canada by SANOFI-AVENTIS CANADA INC.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Insulin Aspart is classified under “INSULINS AND ANALOGUES” (ATC A10AB).

Recent changes

Common questions

What is Insulin Aspart used for?

A rapid-acting insulin used to control blood sugar at mealtimes in diabetes.

When will Insulin Aspart be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Insulin Aspart in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (insulins and analogues)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.